Susquehanna International Group, LLP Evaxion Biotech A/S Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$0.48 - $1.33 $816 - $2,261	-1,700 Reduced 13.39%	11,000 $9,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.74 $14,224 - $22,098	12,700 New	12,700 $16,000
Q4 2022 Feb 14, 2023	SELL	$1.7 - $30.2 $345,950 - $6.15 Million	-203,500 Reduced 83.03%	41,600 $73,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $27.7 $99,370 - $1.45 Million	52,300 Added 27.13%	245,100 $645,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.07 $123,200 - $236,390	77,000 Added 66.49%	192,800 $376,000
Q1 2022 May 16, 2022	BUY	$2.66 - $4.65 $273,980 - $478,950	103,000 Added 804.69%	115,800 $353,000
Q4 2021 Feb 14, 2022	BUY	$4.0 - $12.68 $51,200 - $162,304	12,800 New	12,800 $57,000

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $35.7M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.